| ■ 영문 제목 : Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02283 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 100 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 전립선암 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (종양 바이오 마커 검사, 화상 진단, 생검, 기타)와 용도별 시장규모 (55세 이하, 55~75세, 75세 이상) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 전립선암 진단 시장 점유율 - 지역별 전립선암 진단 시장규모 - 주요지역의 종류별 시장규모 (종양 바이오 마커 검사, 화상 진단, 생검, 기타) - 주요지역의 용도별 시장규모 (55세 이하, 55~75세, 75세 이상) - 미주의 전립선암 진단 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 전립선암 진단 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 전립선암 진단 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 전립선암 진단 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 전립선암 진단 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Prostate Cancer Diagnostics will have significant change from previous year. By the most conservative estimates of global Prostate Cancer Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12250 million in 2020. Over the next five years the Prostate Cancer Diagnostics market will register a 8.1% CAGR in terms of revenue, the global market size will reach US$ 16750 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Age Below 55
Age 55-75
Age Above 75
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
1 Scope of the Report 2 Executive Summary 3 Prostate Cancer Diagnostics Market Size by Players 4 Prostate Cancer Diagnostics by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Prostate Cancer Diagnostics Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Prostate Cancer Diagnostics Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Tumor Biomarker Tests Table 3. Major Players of Imaging Table 4. Major Players of Biopsy Table 5. Major Players of Other Table 6. Prostate Cancer Diagnostics Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Prostate Cancer Diagnostics Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Prostate Cancer Diagnostics Market Size Market Share by Type (2016-2021) Table 9. Prostate Cancer Diagnostics Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Prostate Cancer Diagnostics Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Prostate Cancer Diagnostics Market Size Market Share by Application (2016-2021) Table 12. Global Prostate Cancer Diagnostics Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Prostate Cancer Diagnostics Revenue Market Share by Players (2019-2021E) Table 14. Prostate Cancer Diagnostics Key Players Head office and Products Offered Table 15. Prostate Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Prostate Cancer Diagnostics Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Prostate Cancer Diagnostics Market Size Market Share by Regions 2016-2021 Table 20. Americas Prostate Cancer Diagnostics Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Prostate Cancer Diagnostics Market Size Market Share by Country (2016-2021) Table 22. Americas Prostate Cancer Diagnostics Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Prostate Cancer Diagnostics Market Size Market Share by Type (2016-2021) Table 24. Americas Prostate Cancer Diagnostics Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Prostate Cancer Diagnostics Market Size Market Share by Application (2016-2021) Table 26. APAC Prostate Cancer Diagnostics Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Prostate Cancer Diagnostics Market Size Market Share by Region (2016-2021) Table 28. APAC Prostate Cancer Diagnostics Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Prostate Cancer Diagnostics Market Size Market Share by Type (2016-2021) Table 30. APAC Prostate Cancer Diagnostics Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Prostate Cancer Diagnostics Market Size Market Share by Application (2016-2021) Table 32. Europe Prostate Cancer Diagnostics Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Prostate Cancer Diagnostics Market Size Market Share by Country (2016-2021) Table 34. Europe Prostate Cancer Diagnostics Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Prostate Cancer Diagnostics Market Size Market Share by Type (2016-2021) Table 36. Europe Prostate Cancer Diagnostics Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Prostate Cancer Diagnostics Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Prostate Cancer Diagnostics Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Prostate Cancer Diagnostics Table 45. Key Application and Potential Industries of Prostate Cancer Diagnostics Table 46. Key Challenges of Prostate Cancer Diagnostics Table 47. Key Trends of Prostate Cancer Diagnostics Table 48. Global Prostate Cancer Diagnostics Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Prostate Cancer Diagnostics Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Prostate Cancer Diagnostics Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Application (2021-2026) Table 54. OPKO Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 55. OPKO Prostate Cancer Diagnostics Product Offered Table 56. OPKO Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. OPKO Main Business Table 58. OPKO Latest Developments Table 59. Genomic Health Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 60. Genomic Health Prostate Cancer Diagnostics Product Offered Table 61. Genomic Health Main Business Table 62. Genomic Health Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Genomic Health Latest Developments Table 64. Abbott Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 65. Abbott Prostate Cancer Diagnostics Product Offered Table 66. Abbott Main Business Table 67. Abbott Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Abbott Latest Developments Table 69. Beckman Coulter Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 70. Beckman Coulter Prostate Cancer Diagnostics Product Offered Table 71. Beckman Coulter Main Business Table 72. Beckman Coulter Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Beckman Coulter Latest Developments Table 74. Siemens Healthcare Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 75. Siemens Healthcare Prostate Cancer Diagnostics Product Offered Table 76. Siemens Healthcare Main Business Table 77. Siemens Healthcare Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 78. Siemens Healthcare Latest Developments Table 79. bioMeriux Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 80. bioMeriux Prostate Cancer Diagnostics Product Offered Table 81. bioMeriux Main Business Table 82. bioMeriux Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 83. bioMeriux Latest Developments Table 84. Roche Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 85. Roche Prostate Cancer Diagnostics Product Offered Table 86. Roche Main Business Table 87. Roche Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 88. Roche Latest Developments Table 89. MDx Health Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 90. MDx Health Prostate Cancer Diagnostics Product Offered Table 91. MDx Health Main Business Table 92. MDx Health Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 93. MDx Health Latest Developments Table 94. DiaSorin Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 95. DiaSorin Prostate Cancer Diagnostics Product Offered Table 96. DiaSorin Main Business Table 97. DiaSorin Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 98. DiaSorin Latest Developments Table 99. Myriad Genetics Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 100. Myriad Genetics Prostate Cancer Diagnostics Product Offered Table 101. Myriad Genetics Main Business Table 102. Myriad Genetics Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 103. Myriad Genetics Latest Developments Table 104. Ambry Genetics Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors Table 105. Ambry Genetics Prostate Cancer Diagnostics Product Offered Table 106. Ambry Genetics Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 107. Ambry Genetics Main Business Table 108. Ambry Genetics Latest Developments List of Figures Figure 1. Prostate Cancer Diagnostics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Prostate Cancer Diagnostics Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Prostate Cancer Diagnostics Market Size Market Share by Type in 2020 Figure 7. Prostate Cancer Diagnostics in Age Below 55 Figure 8. Global Prostate Cancer Diagnostics Market: Age Below 55 (2016-2021) & ($ Millions) Figure 9. Prostate Cancer Diagnostics in Age 55-75 Figure 10. Global Prostate Cancer Diagnostics Market: Age 55-75 (2016-2021) & ($ Millions) Figure 11. Prostate Cancer Diagnostics in Age Above 75 Figure 12. Global Prostate Cancer Diagnostics Market: Age Above 75 (2016-2021) & ($ Millions) Figure 13. Global Prostate Cancer Diagnostics Market Size Market Share by Application in 2020 Figure 14. Global Prostate Cancer Diagnostics Revenue Market Share by Player in 2020 Figure 15. Global Prostate Cancer Diagnostics Market Size Market Share by Regions (2016-2021) Figure 16. Americas Prostate Cancer Diagnostics Market Size 2016-2021 ($ Millions) Figure 17. APAC Prostate Cancer Diagnostics Market Size 2016-2021 ($ Millions) Figure 18. Europe Prostate Cancer Diagnostics Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Prostate Cancer Diagnostics Market Size 2016-2021 ($ Millions) Figure 20. Americas Prostate Cancer Diagnostics Market Size Market Share by Country in 2020 Figure 21. Americas Prostate Cancer Diagnostics Market Size Market Share by Type in 2020 Figure 22. Americas Prostate Cancer Diagnostics Market Size Market Share by Application in 2020 Figure 23. United States Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Prostate Cancer Diagnostics Market Size Market Share by Regions in 2020 Figure 27. APAC Prostate Cancer Diagnostics Market Size Market Share by Type in 2020 Figure 28. APAC Prostate Cancer Diagnostics Market Size Market Share by Application in 2020 Figure 29. China Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 33. India Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Prostate Cancer Diagnostics Market Size Market Share by Country in 2020 Figure 36. Europe Prostate Cancer Diagnostics Market Size Market Share by Type in 2020 Figure 37. Europe Prostate Cancer Diagnostics Market Size Market Share by Application in 2020 Figure 38. Germany Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 39. France Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Application in 2020 Figure 46. Egypt Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Prostate Cancer Diagnostics Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 52. APAC Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 53. Europe Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 55. United States Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 56. Canada Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 57. Mexico Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 58. Brazil Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 59. China Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 60. Japan Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 61. Korea Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 63. India Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 64. Australia Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 65. Germany Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 66. France Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 67. UK Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 68. Italy Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 69. Russia Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 70. Spain Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 71. Egypt Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 72. South Africa Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 73. Israel Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 74. Turkey Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Prostate Cancer Diagnostics Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 전립선암 진단 시장예측 2021년-2026년] (코드 : LPI-2201K02283) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 전립선암 진단 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |